Clinical Trials on Lifestyle Factors in Korea, Republic of
Total 43 results
-
Yonsei UniversityCompletedFibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration Gastric Cancer, INCB054828, PaclitaxelKorea, Republic of
-
Asan Medical CenterAstraZenecaCompletedHypertension | Cardiovascular Risk FactorsKorea, Republic of
-
Ulsan University HospitalRecruitingCardiovascular Diseases | Malignancy | Risk FactorKorea, Republic of
-
Seoul National University HospitalInje University; Kangbuk Samsung HospitalRecruitingDiabetes Mellitus, Type 2 | Lifestyle Risk ReductionKorea, Republic of
-
Seoul National University HospitalUnknownArthroplasty | Complication | Risk Factor | Elderly PatientKorea, Republic of
-
The Catholic University of KoreaMinistry for Health Welfare and Family AffairsCompletedType 2 Diabetes | Lifestyle Intervention | Glucose Control | Internet CommunicationKorea, Republic of
-
Wonju Severance Christian HospitalRecruitingMyocardial Injury | Complications | Therapy | Carbon Monoxide Poisoning | Image, Body | Neurologic Deficits | Prognostic FactorsKorea, Republic of
-
The Catholic University of KoreaUnknownDrug-Related Side Effects and Adverse Reactions | Epidermal Growth FactorKorea, Republic of
-
Hallym University Kangnam Sacred Heart HospitalCompletedHyperpigmentation | Epidermal Growth Factor | Post Inflammatory Hyperpigmentation | Nd-yttrium Aluminum Garnet LaserKorea, Republic of
-
The Catholic University of KoreaUnknownDrug-Related Side Effects and Adverse Reactions | Epidermal Growth FactorKorea, Republic of
-
Yonsei UniversityCompletedDoctors Attending a Central Line Insertion Training Courses for New Residents of a University Hospital From March 2017 to June 2017 | Physicians Who Had Less Than 10 Ultrasound Guided Internal Jugular Vein Cannulation Participate in This StudyKorea, Republic of
-
Javad NasrollahzadehShahid Beheshti University of Medical SciencesCompletedCardiovascular Risk FactorIran, Islamic Republic of
-
Shahid Beheshti UniversityCompletedBlood Pressure | Cardiovascular Risk Factor | Lipid ProfileIran, Islamic Republic of
-
Isfahan University of Medical SciencesCompletedInflammation | Oxidative Stress | Fibrinolytic Markers | Blood Pressure and Cardiorenal Risk FactorsIran, Islamic Republic of
-
Shahid Beheshti UniversityShahid Beheshti University of Medical SciencesCompletedCardiovascular Risk FactorIran, Islamic Republic of
-
Georgetown UniversityCompletedSedentary LifestyleUnited States
-
AstraZenecaCompletedThe Aim of This Study is to Investigate the Frequency and Related Risk Factors of Recurrence, and Quality of Life in Patients With GERD After Treatment With PPIKorea, Republic of
-
University of OxfordBritish Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaboratorsRecruitingCardiovascular Diseases | Cardiovascular Risk FactorsUnited Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
-
University Psychiatric Clinics BaselCompletedHealthy | Healthy Lifestyle | TeenagerSwitzerland
-
National Institutes of Health Clinical Center (CC)CompletedSocioeconomic Factors | Low-Income Population | Health StatusUnited States
-
AryoGen Pharmed Co.CompletedFactor VII DeficiencyIran, Islamic Republic of
-
University of Southern DenmarkRegion of Southern Denmark; Odense Patient Data Explorative Network; ENIGMA Solutions... and other collaboratorsActive, not recruitingCardiovascular Risk Factor | Risk CommunicationDenmark
-
AryoGen Pharmed Co.CompletedFactor VII Deficiency | Hemophilia A With Inhibitor | Hemophilia B With Inhibitor | Glanzmann's ThrombastheniaIran, Islamic Republic of
-
Royal Marsden NHS Foundation TrustNational Institute for Health Research, United KingdomActive, not recruitingBreast Cancer | Lifestyle Risk ReductionUnited Kingdom
-
BioMarin PharmaceuticalRecruitingHemophilia A With Inhibitor | Hemophilia A With Anti Factor VIIIUnited States, United Kingdom, Taiwan, Israel, Korea, Republic of, South Africa, Brazil, Italy, Germany
-
Bioverativ, a Sanofi companyCompletedFactor VIII DeficiencyUnited States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Janssen Research & Development, LLCRecruitingUrinary Bladder Neoplasms | Receptors, Fibroblast Growth FactorKorea, Republic of, United States, Germany, Spain, Netherlands
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
Black Diamond Therapeutics, Inc.RecruitingNon-Small Cell Lung Cancer | NSCLC | Metastatic Lung Cancer | Metastatic Lung Non-Small Cell Carcinoma | EGF-R Positive Non-Small Cell Lung Cancer | Advanced Lung Carcinoma | EGFR-TKI Resistant Mutation | Advanced Non-Small Cell Squamous Lung Cancer | Epidermal Growth Factor Receptor C797S | Epidermal...Korea, Republic of, United States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FVII DeficiencySlovakia, Israel, Spain, India, Iran, Islamic Republic of, Pakistan, Turkey, Germany, Serbia, Italy, Greece, Thailand, France, United States, Hong Kong, Venezuela
-
AmgenRecruitingSolid TumorsCanada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Italy, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Finland and more
-
Merck KGaA, Darmstadt, GermanyCompletedEpidermal Growth Factor Receptor (EGFR) Expressing Metastatic Colorectal CancerSweden, Australia, Brazil, Bulgaria, France, Italy, Korea, Republic of, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Hungary, Poland, Romania, Austria, Belgium, Finland, Netherlands, Slovakia, Greece, Ta... and more
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...RecruitingCardiovascular Diseases | Lung Diseases | Cancer | Risk Factor, Cardiovascular | Health Behavior | Injuries | Environmental Exposure | Renal Disease | Communicable DiseaseIndia, Saudi Arabia, Iran, Islamic Republic of, Peru, Pakistan, Argentina, Bangladesh, Brazil, Canada, Chile, China, Colombia, Kazakhstan, Kyrgyzstan, Malaysia, Palestinian Territory, occupied, Philippines, Poland, Russian Federation and more
-
AstraZenecaCompletedSmoking | Hypertension | Obesity | Diabetes | Hyperlipidemia | Cardiovascular Risk FactorsSweden, France, Russian Federation, Spain, Turkey, United Kingdom, Germany, Norway, Austria, Belgium, Switzerland, Greece
-
Daiichi SankyoDaiichi Sankyo Co., Ltd.Active, not recruitingNon-Small Cell Lung Cancer Metastatic | Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor ReceptorUnited States, Spain, Korea, Republic of, France, United Kingdom, Taiwan, Australia, Japan, China, Netherlands, Italy, Germany, Austria, Belgium, Bulgaria, Singapore
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) MutationsUnited States, Japan, Spain, France, Australia, Italy, Korea, Republic of, United Kingdom, Canada, Germany, Turkey, Hong Kong
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.TerminatedTriple Negative Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Negative Breast CancerUnited States
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Congenital FXIII DeficiencyFrance, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
American Thrombosis and Hemostasis NetworkSanofi; Pfizer; Genentech, Inc.; CSL Behring; Hemophilia of Georgia, Inc.; Hemab TherapeuticsRecruitingHemophilia | Thrombosis | Thrombophilia | Sickle Cell Disease | Thalassemia | Bleeding Disorder | Von Willebrand Diseases | Factor IX Deficiency | Connective Tissue Disorder | Factor VIII Deficiency | Hematologic Disorder | Rare Bleeding Disorder | Platelet DisorderUnited States
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of